Abivax SA American Depositary Shares

Yahoo Finance • 9 days ago

What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors

Key Points Saturn V sold 1,504,880 shares of Ocular Therapeutix in the first quarter; the estimated transaction value was $14.34 million. Meanwhile, the quarter-end position value declined by $18.27 million, reflecting both share sales an... Full story

Yahoo Finance • 10 days ago

Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?

Key Points Initiated 1,446,375-share position in Beam Therapeutics; estimated trade size $40.13 million (quarterly average price). Quarter-end stake valued at $34.47 million, a net position change reflecting both trading and price movemen... Full story

Yahoo Finance • 10 days ago

Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?

Key Points ADAR1 Capital Management added 829,963 shares of Crinetics Pharmaceuticals; estimated trade size $37.07 million based on quarterly average pricing. Quarter-end position value increased by $26.98 million, reflecting both trading... Full story

Yahoo Finance • 10 days ago

Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish

Octagon Capital Advisors cut its stake in Dianthus Therapeutics(NASDAQ:DNTH) by 470,000 shares, an estimated $27.22 million trade based on quarterly average pricing, according to a May 15, 2026 SEC filing. What happened According to a SE... Full story

Yahoo Finance • 11 days ago

Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares

On May 15, 2026, HighVista Strategies disclosed it sold 70,503 shares of Maze Therapeutics(NASDAQ:MAZE) in Q1 2026, an estimated $3.11 million trade based on quarterly average pricing. What happened According to a Securities and Exchange... Full story

Yahoo Finance • 11 days ago

Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares

On May 15, 2026, HighVista Strategies disclosed a purchase of 96,218 shares of Tyra Biosciences(NASDAQ:TYRA), estimated at $3.11 million based on quarterly average pricing. What happened According to its SEC filing dated May 15, 2026, Hi... Full story

Yahoo Finance • 11 days ago

This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million

HighVista Strategies reported a sale of 238,243 shares of Viridian Therapeutics(NASDAQ:VRDN) in its May 15, 2026, SEC filing, an estimated $7.08 million trade based on quarterly average pricing. What happened According to a SEC filing da... Full story

Yahoo Finance • 22 days ago

ABIVAX (ABVX) Announces $90M Agreement to Repurchase Royalty Certificates

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the best young stocks to buy and hold for the next decade. On May 5, ABIVAX announced a $90 million agreement to repurchase and cancel all royalty certificates issued in September 2022. The tr... Full story

Yahoo Finance • last month

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents PARIS, France, April 20, 2026, 10:05 PM CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a cl... Full story

Yahoo Finance • last month

Bright Prospects Ahead for Abivax (ABVX)

Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here. Cedar Grove Capital Management’s Multi-Strategy Composite posted a -23.... Full story

Yahoo Finance • last month

ABIVAX (ABVX) Appoints Michael Nesrallah as Chief Commercial Officer

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the 7 Best Strong Buy European Stocks to Invest In. On April 2, 2026, ABIVAX Société Anonyme (NASDAQ:ABVX) appointed Michael Nesrallah as chief commercial officer. Michael Nesrallah will lead... Full story

Yahoo Finance • 2 months ago

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France – April 1, 2026 – 10:05 PM CEST – Abivax... Full story

Yahoo Finance • 2 months ago

2 Healthcare Stocks That Could Soar Over the Next 5 Years

Key Points These two biotechs could ride the wave of significant clinical progress. However, both carry above-average risk. 10 stocks we like better than Moderna › While the stock market is facing significant volatility right now, there... Full story

Yahoo Finance • 2 months ago

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch

Key Points Cormorant Asset Management established a new stake in Olema Pharmaceuticals, purchasing 2,750,000 shares in the fourth quarter. The value of the position was $68.75 million at quarter-end. The new position places Olema outside... Full story

Yahoo Finance • 2 months ago

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

Key Points Eversept Partners added 264,468 shares of Vera Therapeutics in the fourth quarter; the estimated transaction value was $9.39 million based on quarterly average pricing. Meanwhile, the quarter-end position value increased in val... Full story

Yahoo Finance • 2 months ago

AstraZeneca Abivax Talks Highlight Biotech Expansion And Valuation Upside Potential

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. AstraZeneca (LSE:AZN) has entered exclusive negotiations to potentially acquire biotech firm Abi... Full story

Yahoo Finance • 2 months ago

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

British drugmaker AstraZeneca Plc has emerged as the leading contender to acquire French biotech Abivax SA, following the company's dramatic valuation surge after strong clinical progress tied to its lead drug candidate. The potential tak... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Retreat Late Afternoon

Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index down 1.3% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Lower in Afternoon Trading

Health care stocks declined Thursday afternoon, with the NYSE Health Care Index and the State Street PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Qualcomm, Booking Holdings upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Loop Capital upgraded Qualcomm (QCOM)... Full story